Sign Up to Receive Your Personalised Learning Resources
CONFERENCE HUB
Per Ljungman, EBMT23: Outcomes and mortality in cytomegalovirus seropositive allogeneic stem cell transplantation patients with COVID-19
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Anna Sureda, EBMT23: Improvements in outcomes in autologous stem cell transplantation for patients with Hodgkin lymphoma
View
Contemporary insights on the management of sickle cell disease: Focus on complications and recent advances in therapy
View
The evolving treatment landscape in relapsed/refractory multiple myeloma
View
The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials
View
Per Ljungman, EBMT23: Outcomes and mortality in cytomegalovirus seropositive allogeneic stem cell transplantation patients with COVID-19
View
John Mascarenhas, EHA 2023: Phase II MANIFEST trial: Pelabresib combined with ruxolitinib for patients with myelofibrosis
View
Renoir phase 3 study – rituximab and lenalidomide versus rituximab for elderly patients with r/r follicular lymphoma: Umberto Vitolo, ASH 2023
View
Mark Levis, EHA 2023: MORPHO trial of gilteritinib as post-transplant maintenance for FLT3-ITD acute myeloid leukaemia
View
Johan de Munter, EBMT 2023: Highlights from the Nurses Group Keynote Lecture
View
Marina Kremyanskaya, EHA 2023: Findings of the REVIVE study of rusfertide in polycythaemia vera
View